Department of Neurosurgery, 401 General Military Hospital of Athens, Athens, Greece.
Center of Orthopaedics and Regenerative Medicine (C.O.R.E.), Center for Interdisciplinary Research and Innovation (C.I.R.I.), Aristotle University Thessaloniki, Thessaloniki, Greece.
Interv Neuroradiol. 2022 Feb;28(1):70-83. doi: 10.1177/15910199211014701. Epub 2021 May 10.
Carotid cavernous fistulas (CCFs) are rare, usually follow head trauma or aneurysmal rupture. Recent treatment options include endovascular techniques such as flow diversion devices (FDDs).
To present our case treated with FDD application with transarterial cavernous-sinus coiling and present a systematic review on the use and effectiveness of FDDs in CCF treatment.
We present our case of CCF treatment with FDD. A search was also conducted in PubMed, EMBASE and Cochrane until November 2020. Reference lists were also cross-checked.
Including our case, thirty-eight patients were identified with a CCF that was treated with FDDs in sixteen studies. Twenty-two patients were females, nine were males and the rest unidentified. The mean age was 52,6 years (range 17-86, SD± 19.28). Thirty-six patients suffered from direct and two from indirect CCFs. Single FDD was used in four cases, single FDD with embolic materials in eleven cases, multiple overlapping FDDs were used in six cases and multiple overlapping FDDs with embolic materials were used in seventeen cases. Thirty-five patients (92,1%) had clinical improvement, immediate angiographic occlusion was seen in 44,7% of the cases, while long-term occlusion rate was 100% but with variable follow-up periods. One patient (2,6%) presented with a neurological deficit related to FDD deployment.
Targeted treatment of CCFs with single or overlapping FDDs with or without adjunct embolic agents offers a high success rate, both clinically and long-term angiographically compared to other endovascular methods alone. However, further research with multi-center prospective trials is warranted.
颈动脉海绵窦瘘(CCF)很少见,通常继发于头部外伤或动脉瘤破裂。最近的治疗选择包括血管内技术,如血流导向装置(FDD)。
介绍我们使用 FDD 治疗 CCF 的病例,并对 FDD 在 CCF 治疗中的应用和效果进行系统评价。
我们报告了一例使用 FDD 治疗 CCF 的病例,并在 PubMed、EMBASE 和 Cochrane 进行了检索,检索时间截至 2020 年 11 月。还交叉检查了参考文献列表。
包括我们的病例在内,在 16 项研究中,有 38 例 CCF 患者使用 FDD 治疗。22 例为女性,9 例为男性,其余性别不详。平均年龄为 52.6 岁(范围 17-86,SD±19.28)。36 例患者为直接瘘,2 例为间接瘘。4 例使用单个 FDD,11 例使用单个 FDD 联合栓塞材料,6 例使用多个重叠 FDD,17 例使用多个重叠 FDD 联合栓塞材料。35 例(92.1%)患者临床症状改善,即刻血管造影闭塞率为 44.7%,长期闭塞率为 100%,但随访时间不同。1 例(2.6%)患者因 FDD 植入出现与神经功能相关的并发症。
与其他单纯血管内方法相比,使用单个或重叠的 FDD 联合或不联合辅助栓塞剂治疗 CCF,在临床和长期血管造影方面均具有较高的成功率。然而,仍需要进行多中心前瞻性试验的进一步研究。